Rankings
▼
Calendar
TMDX Q4 2021 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena
TMDX
TransMedics Group, Inc.
$5B
Q4 2021 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$10M
+26.8% YoY
Gross Profit
$7M
72.3% margin
Operating Income
-$11M
-117.2% margin
Net Income
-$13M
-131.0% margin
EPS (Diluted)
$-0.46
QoQ Revenue Growth
+80.0%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$10M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$135M
Total Liabilities
$67M
Stockholders' Equity
$68M
Cash & Equivalents
$26M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$10M
$8M
+26.8%
Gross Profit
$7M
$5M
+44.7%
Operating Income
-$11M
-$6M
-92.1%
Net Income
-$13M
-$6M
-100.7%
Revenue Segments
Ocs Heart Product
$6M
63%
Ocs Lung Product
$2M
22%
Ocs Liver Product
$1M
15%
Geographic Segments
UNITED STATES
$7M
62%
Non Us And Uk
$4M
38%
← FY 2021
All Quarters
Q1 2022 →